MYRIAD GENETICS INC.

Myriad Genetics Receives Expanded Coverage in Japan for Use of BRACAnalysis® Diagnostic System as a Companion Diagnostic for Lynparza® in Early-Stage Breast Cancer

25 авг 2022 15:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics Partners with Institut für Hämopathologie Hamburg and Centre Georges-Francois LeClerc to Expand Access to Genetic Testing in Europe

16 авг 2022 00:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics Reports Second Quarter Financial Results

04 авг 2022 06:05:01 Источник Nasdaq GlobeNewswire

Myriad Genetics to Release 2022 Second-Quarter Financial Results on Aug. 4, 2022

28 июл 2022 15:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics to Share Update on Business Transformation, Research and Development Pipeline, and Growth Plans at Investor Day on Aug. 11, 2022

19 июл 2022 16:07:33 Источник Nasdaq GlobeNewswire

Access to Myriad Genetics’ GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial

12 июл 2022 15:12:38 Источник Nasdaq GlobeNewswire

Myriad Genetics Issues Inaugural Environmental, Social and Governance Report

28 июн 2022 15:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics Teams Up with Epic to Make Genetic Testing Accessible to More Patients with Electronic Health Record (EHR) Integration

23 июн 2022 15:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics CEO Paul Diaz to Speak at Goldman Sachs 43rd Annual Global Healthcare Conference

09 июн 2022 16:30:00 Источник Nasdaq GlobeNewswire

Myriad Genetics Showcases Advancements in Precision Medicine with Recent Oncology Portfolio Expansion and New Data Presentations at ASCO 2022

26 май 2022 17:30:00 Источник Nasdaq GlobeNewswire

Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022

05 май 2022 08:00:02 Источник Nasdaq GlobeNewswire

Myriad Genetics CEO Paul Diaz to Speak at Bank of America Securities 2022 Healthcare Conference

04 май 2022 15:05:02 Источник Nasdaq GlobeNewswire

Myriad Genetics Expands Partnership with Intermountain Precision Genomics to Add Liquid Biopsy Therapy Selection Offering to Portfolio of Precise™ Oncology Solutions

03 май 2022 15:15:00 Источник Nasdaq GlobeNewswire

Myriad Genetics to Release First-Quarter 2022 Financial Results on May 5, 2022

28 апр 2022 15:05:01 Источник Nasdaq GlobeNewswire

2 Out of 3 Women With Depression or Anxiety Say They’ve Reached Their “Breaking Point” Yet More than Half Wait a Year Before Seeking Treatment

26 апр 2022 06:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer

11 мар 2022 18:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies

08 мар 2022 06:22:47 Источник Nasdaq GlobeNewswire

Myriad Genetics CEO Paul Diaz to Speak at 42nd Annual Cowen Health Care Conference

02 мар 2022 15:30:00 Источник Nasdaq GlobeNewswire

Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives

24 фев 2022 08:00:02 Источник Nasdaq GlobeNewswire

New Analysis Published in Peer-reviewed Psychiatry Research Shows Advantages of Combinatorial Algorithm of GeneSight® Psychotropic Test

23 фев 2022 15:30:00 Источник Nasdaq GlobeNewswire